Reverse-transcriptase inhibitor - PDFSEARCH.IO - Document Search Engine

Reverse-transcriptase inhibitor
Results: 328

#	Item
81	Lopinavir/ritonavir M01-384 Abbreviated Clinical Study Report R&D[removed] Add to Reading List Source URL: www.abbvie.com Language: English - Date: 2014-12-18 16:27:55 Pharmacology Carbamates Fixed dose combination Organofluorides Antiretroviral drug Lopinavir/ritonavir Reverse-transcriptase inhibitor Zidovudine Lamivudine Chemistry Protease inhibitors Organic chemistry
82	Educa&ng Nurses About An&retrovirals and HIV Preven&on -‐ State of the Science, Uptake Challenges, and Barriers Dr Valérie Martinez-Pourcher Pitié- Add to Reading List Source URL: www.iapac.org Language: English - Date: 2014-10-20 08:30:46 Antiretroviral drug AIDS HIV Zidovudine Reverse-transcriptase inhibitor HIV/AIDS Health Medicine
83	FDA Tentative Approval[removed]Abacavir Sulfate Oral Solution (20 mg/mL) Aurobindo Pharma, Ltd. 1 Add to Reading List Source URL: apps.who.int Language: English - Date: 2009-10-16 03:51:12 Cyclopropanes Pharmacology Health Medicine GlaxoSmithKline Organofluorides Lamivudine Antiretroviral drug Reverse-transcriptase inhibitor Purines Fixed dose combination Abacavir
84	WHOPAR [FDA] Aurobindo Abacavir 300 mg tabs Add to Reading List Source URL: apps.who.int Language: English - Date: 2009-10-16 03:51:10 Cyclopropanes Health Medicine Chemistry GlaxoSmithKline Lamivudine Antiretroviral drug Reverse-transcriptase inhibitor AIDS Purines Fixed dose combination Abacavir
85	Treatment Expansion in Access & Emerging Markets James F Rooney MD VP Medical Affairs Gilead Sciences Add to Reading List Source URL: regist2.virology-education.com Language: English - Date: 2014-11-06 16:52:00 Microbiology Tenofovir Emtricitabine Antiretroviral drug Hepatitis B Viral hepatitis Generic drug Emtricitabine/tenofovir/efavirenz Reverse-transcriptase inhibitor Gilead Sciences Pharmacology Medicine
86	FDA Tentative Approval November 8, 2005 Lamivudine Oral Solution (10 mg/mL) Aurobindo Pharma, Ltd. 1 Add to Reading List Source URL: apps.who.int Language: English - Date: 2009-12-08 04:25:30 Organic chemistry Cyclopropanes Antiretroviral drug Reverse-transcriptase inhibitor Fixed dose combination Purines Non-nucleoside reverse transcriptase inhibitors Abacavir Organofluorides Chemistry Lamivudine
87	FDA Approval December 29, 2008 Stavudine Capsules 15, 20, 30, 40 mg Hetero Drugs Ltd. 1 Add to Reading List Source URL: apps.who.int Language: English - Date: 2010-02-09 07:18:52 Stavudine Pharmacology Antiretroviral drug Adverse effect Reverse-transcriptase inhibitor Chemistry Orlistat Medicine Bristol-Myers Squibb Health
88	USFDA Tentative Approval[removed]Didanosine chewable/dispersible buffered Tablets 100mg, 150mg, 200mg Aurobindo Pharma, Ltd. 1 Add to Reading List Source URL: apps.who.int Language: English - Date: 2009-12-08 04:14:10 Pharmacology Bristol-Myers Squibb Didanosine Zalcitabine Amoxicillin Tenofovir Ribavirin Antiretroviral drug Reverse-transcriptase inhibitor Chemistry Organic chemistry Purines
89	FDA Tentative Approval[removed]Efavirenz Capsules 50 mg, 100 mg, and 200 mg Aurobindo Pharma, Ltd. 1 Add to Reading List Source URL: apps.who.int Language: English - Date: 2009-11-10 08:30:56 Non-nucleoside reverse transcriptase inhibitors Cyclopropanes Organofluorides Alkynes Efavirenz Antiretroviral drug Reverse-transcriptase inhibitor Simvastatin Atazanavir Chemistry Bristol-Myers Squibb Organic chemistry
90	FDA Approval March 20, 2009 Stavudine Powder for Oral Solution USP, 1 mg/mL Cipla Ltd. 1 Add to Reading List Source URL: apps.who.int Language: English - Date: 2010-06-28 08:13:34 Stavudine Pharmacology Cipla Antiretroviral drug Adverse effect Reverse-transcriptase inhibitor Bristol-Myers Squibb Medicine Health

UPDATE